Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Common Stock | 157K | $403K | $2.56 | Mar 10, 2025 | Direct |
Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Restricted Stock Units | 9.75K | $25K | $2.56 | Mar 7, 2025 | Direct |
Sana Biotechnology, Inc. | Acting Chief Financial Officer and Principal Accounting Officer | Stock Option (Right to Buy) | 188K | Mar 6, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SANA | Sana Biotechnology, Inc. | Mar 6, 2025 | 5 | -$2.14K | 4 | Mar 10, 2025 | Acting Chief Financial Officer and Principal Accounting Officer |
SANA | Sana Biotechnology, Inc. | Mar 2, 2025 | 3 | -$1.25K | 4 | Mar 3, 2025 | Acting Chief Financial Officer and Principal Accounting Officer |
SANA | Sana Biotechnology, Inc. | Jan 2, 2025 | 3 | -$2.58K | 4 | Jan 3, 2025 | Acting Chief Financial Officer and Principal Accounting Officer |
SANA | Sana Biotechnology, Inc. | Oct 4, 2024 | 0 | $0 | 3 | Oct 15, 2024 | Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney |